Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
– Four sites across the country participating in clinical trial for lead product candidate PH-762– Two patients have already completed treatmentRead...
Month: April 2024
Lilium Begins Integration of Garmin Standby Flight Instruments for the Lilium Jet
MUNICH, Germany, April 02, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ: LILM), developer of the first all-electric vertical take-off and...
Lincoln Electric Schedules Webcast for First Quarter 2024 Results
Contacts Amanda Butler Vice President, Investor Relations & Communications Tel: (216) 383-2534 Email: Amanda_Butler@lincolnelectric.com Lincoln Electric Holdings, Inc., (the “Company”)...
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
– Abiprubart Phase 2b trial in Sjogren’s Disease planned to initiate in 2H 2024 –– Abiprubart Phase 2 Cohort 4...
Kforce Inc. to Announce First Quarter Results on April 29, 2024
TAMPA, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- Kforce Inc. (NASDAQ: KFRC), a provider of professional staffing services and solutions,...
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
Submission based on data from Phase 2b HERIZON-BTC-01 trial, which met its primary endpoint in patients receiving zanidatamab for previously...
FTAI Aviation Commences Cash Tender Offer for Any and All of Its Outstanding 6.50% Senior Notes Due 2025
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI), a Cayman Islands exempted company (the “Company”...
Coda Octopus Group Reports that its Echoscope® Technology used as the Primary Survey Tool in the Francis Scott Key Bridge ongoing salvage operations.
ORLANDO, FL, April 02, 2024 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA), a global...
Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities
REDWOOD CITY, CA / ACCESSWIRE / April 2, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading Technology-as-a-Service...
Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
Transaction consideration provides a significant premium to the Appili shareholdersCombined enterprise expected to provide enhanced synergies and resources to advance...
Avicanna Reports Full Year 2023 Audited Financial Results
$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an increase of 500% from 2022TORONTO,...
Else Nutrition Announces Highly Anticipated First Commercial Launch of its Groundbreaking Plant-Based Infant Formula in Australia; Also Targeting $50B (USD) Plus Asia Pacific Baby & Child Nutrition Markets
Australia Strategically Selected as Beachhead for Commercial Expansion of Else Products Across the Asia Pacific RegionAmazon First to Carry Else’s...
HydroGraph Announces AGM Update
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCBQ: HGCPF) (the “Company” or “HydroGraph”), announces...
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading...
Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a...
Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
Orexo announces that the condition for early redemption of its existing bonds has been fulfilled
UPPSALA, Sweden, April 2, 2024 /PRNewswire/ -- On March 13, 2024, Orexo AB (publ), ("Orexo" or the "Company") (STO:ORX) (OTCQX:ORXOY) announced that the Company intends...
Traws Pharma Announces New Employee Inducement Grants
NEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has...
Knightscope Announces Significant Financial Milestones
Town Hall with CEO and CFO Scheduled for Tonight Technology Innovator Continues Executing on Roadmap to Profitable Growth Contacts Public...
Intuit Launches Intuit for Education and Announces Goal to Help 50M Students Become Financially Literate, Capable, and Confident by 2030
Intuit for Education delivers free, flexible, and interactive financial curriculum for schools New “Hour of Finance Challenge” encourages students to...
US Army Awards $12 Million Contract Extension to Gilat to Sustain Anytime, Anywhere Satellite Connectivity
PETAH TIKVA, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader...
Electra and Eurasian Resources Group Sign Cobalt Supply Agreement
Contacts Heather Smiles Vice President, Investor Relations & Corporate Development Electra Battery Materials Info@ElectraBMC.com 1.416.900.3891 Andrey Belov Group Senior Manager...
Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Contacts Investor Contact: Camilla Zuckero czuckero@castlebiosciences.com Media Contact: Allison Marshall amarshall@castlebiosciences.com Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health...
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies...
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
WAYNE, Pa. and ROCKVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced the addition...
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Contacts Investor Contact Allison Wey Senior Vice President, Investor Relations and Corporate Communications awey@xerispharma.com Xeris Biopharma Holdings, Inc. (Nasdaq: XERS),...
Verve Therapeutics Announces Updates on its PCSK9 Program
Heart-1 clinical trial demonstrated LDL-C reduction of up to 73% at 0.45 mg/kg of VERVE-101Company to pause enrollment in Heart-1...
MEDIA ADVISORY: Broadcast Media Has a Measurement Issue; Can AI Solve It?
Upcoming Veritone and The Center for Sales Strategy webinar to explore how AI is demonstrating campaign performance and creating meaningful...
Sweetwater Brewing Unveils New 420 Variety Pack
ATLANTA, April 02, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast...
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
WALTHAM, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
Scientific content at ASCRS related to EVO ICL™ doubles with 44 posters and presentations STAAR is leading a comprehensive clinical...
Smith Micro Announces New Agreement with a Mobile Operator in the US for Deployment of Its SafePath Platform
U.S. Wireless Carrier Will Launch First Deployment of SafePath Global™ Contacts PR INQUIRIES: Smith Micro Software Paula Yurkovich +1 (412)...
Hughes Enables Worldwide LEO Connectivity with Eutelsat OneWeb Approval of New ESA
Hughes flat panel ESA user terminal approved for commercial availability on the OneWeb LEO Network GERMANTOWN, Md., April 2, 2024 /PRNewswire/...
Sandy Spring Bancorp, Inc. to Webcast First Quarter Earnings Conference Call on April 23, 2024
OLNEY, Md., April 02, 2024 (GLOBE NEWSWIRE) -- Sandy Spring Bancorp, Inc. (Nasdaq: SASR) will announce its first quarter earnings...
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
BASEL, Switzerland and LONDON and NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) and Priovant Therapeutics today...
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
TEL AVIV, Israel and RALEIGH, N.C., April 2, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a...
David Higley Joins Perella Weinberg as Partner
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Perella Weinberg Partners (Nasdaq: PWP), a leading global independent advisory firm, announced...
Powerfleet and MiX Telematics Close Business Combination, Creating New Top-Tier Global AIoT SaaS Provider
A Scaled Day-One Business with Total Revenue of $284 Million, Including $215 Million of Recurring High-Margin SaaS Revenues and Combined...
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity’s Horizons in Oncology Virtual Conference
SAN DIEGO and CALGARY, AB, April 2, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company...
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
LONDON and NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...